Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
ARS Pharmaceuticals (SPRY)
NASDAQ:SPRY
Holding SPRY?
Track your performance easily
See the Price Targets and Ratings of:
SPRY Analyst Ratings
Moderate Buy
2 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
SPRY Stock 12 Month Forecast
Average Price Target
$25.50
▲(53.52% Upside)
| Highest Price Target$30.00 | Average Price Target$25.50 | Lowest Price Target$21.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Cantor Fitzgerald
Reiterated
10/07/24
Leerink Partners
Reiterated
08/26/24
Raymond James
$18→$22
Buy
32.45%
Upside
Reiterated
08/12/24
ARS Pharmaceuticals upgraded to Strong Buy from Outperform at Raymond JamesARS Pharmaceuticals upgraded to Strong Buy from Outperform at Raymond James
Oppenheimer
$19
Buy
14.39%
Upside
Assigned
03/11/24
Neffy's Market Potential and ARS Pharmaceuticals' Buy Rating Reinforced by Clinical Success
William Blair
―
Buy
―
Upgraded
02/20/24
ARS Pharmaceuticals upgraded to Outperform from Market Perform at William BlairARS Pharmaceuticals upgraded to Outperform from Market Perform at William Blair
Best Analysts Covering ARS Pharmaceuticals
Which Analyst Should I Follow If I Want to Buy SPRY and Sell After:
1 Month
xxx
Success Rate
9/10 ratings generated profit
Average Return
+18.77%
assigned a xxx
rating 9 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 90.00% of your transactions generating a profit, with an average return of +18.77% per trade.
3 Months
xxx
Success Rate
7/10 ratings generated profit
Average Return
+20.99%
assigned a xxx
rating 9 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 70.00% of your transactions generating a profit, with an average return of +20.99% per trade.
1 Year
Success Rate
8/10 ratings generated profit
Average Return
+125.90%
assigned a buy rating 9 months ago
Copying Andreas Argyrides's trades and holding each position for 1 Year would result in 80.00% of your transactions generating a profit, with an average return of +125.90% per trade.
2 Years
xxx
Success Rate
10/10 ratings generated profit
Average Return
+215.15%
assigned a xxx
rating 9 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +215.15% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
SPRY Analyst Recommendation Trends
Rating
May 24
Jun 24
Jul 24
Aug 24
Oct 24
Strong Buy
6
4
2
5
6
Buy
1
1
1
2
1
Hold
1
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
8
5
3
7
7
Each month's total comprises the sum of three months' worth of ratings.
SPRY Financial Forecast
SPRY Stock Forecast FAQ
What is SPRY’s average 12-month price target, according to analysts?
Based on analyst ratings, ARS Pharmaceuticals’s 12-month average price target is $25.50.
What is SPRY’s upside potential, based on the analysts’ average price target?
ARS Pharmaceuticals has 53.52% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is SPRY a Buy, Sell or Hold?
ARS Pharmaceuticals has a consensus rating of Moderate Buy which is based on 2 buy ratings, 0 hold ratings and 0 sell ratings.
What is ARS Pharmaceuticals’s price target?
The average price target for ARS Pharmaceuticals is $25.50. This is based on 2 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $30.00 ,the lowest forecast is $21.00. The average price target represents 53.52% Increase from the current price of $16.61.
The highest analyst price target is $30.00 ,the lowest forecast is $21.00. The average price target represents 53.52% Increase from the current price of $16.61.
What do analysts say about ARS Pharmaceuticals?
ARS Pharmaceuticals’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 2 Wall Streets Analysts.
How can I buy shares of SPRY?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.